BlackRock Health Sciences Trust (BME)

BME Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	-0.05	-0.03	-0.04	-0.08	-0.08
Other Revenue	7.78	7.59	8.23	7.81	6.48
Revenue	7.74	7.57	8.19	7.73	6.4
Revenue Growth (YoY)	2.23%	-7.65%	5.98%	20.76%	22.14%
Gross Profit	7.74	7.57	8.19	7.73	6.4
Selling, General & Admin	6	6.64	6.19	6.19	6.35
Operating Expenses	6	6.64	6.19	6.19	6.35
Operating Income	1.73	0.93	2.01	1.54	0.05
Interest Expense	-0	-0	-0	-	-
Currency Exchange Gain (Loss)	0.02	-0	-0.01	-0.01	-0.01
Other Non Operating Income (Expenses)	-4.12	-2.9	0.55	10.12	-9.75
EBT Excluding Unusual Items	-2.37	-1.98	2.55	11.64	-9.7
Gain (Loss) on Sale of Investments	79.34	25.44	17.47	-38.11	68.83
Pretax Income	76.97	23.45	20.02	-26.47	59.13
Income Tax Expense	-	-	-	-	0.01
Net Income	76.97	23.45	20.02	-26.47	59.12
Net Income to Common	76.97	23.45	20.02	-26.47	59.12
Net Income Growth	228.16%	17.17%	-	-	-25.69%
Shares Outstanding (Basic)	13	13	14	14	13
Shares Outstanding (Diluted)	13	13	14	14	13
Shares Change (YoY)	-2.50%	-4.94%	0.60%	6.23%	9.13%
EPS (Basic)	5.96	1.77	1.44	-1.91	4.53
EPS (Diluted)	5.96	1.77	1.44	-1.91	4.53
EPS Growth	236.57%	23.26%	-	-	-31.91%
Dividend Per Share	3.145	2.605	2.556	2.556	2.439
Dividend Growth	20.73%	1.92%	-	4.80%	1.63%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	22.41%	12.25%	24.48%	19.91%	0.84%
Profit Margin	994.98%	309.96%	244.30%	-342.40%	923.46%
EBIT	1.73	0.93	2.01	1.54	0.05
EBIT Margin	22.41%	12.25%	24.48%	19.91%	0.84%
Effective Tax Rate	-	-	-	-	0.02%
Revenue as Reported	7.74	7.57	8.19	7.73	6.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q